MedTrace Logo

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

NCT05800951 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2026-04-17

No results posted yet for this study

Summary

The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.

Conditions

  • Cardiogenic Shock
  • Acute Myocardial Infarction
  • STEMI - ST Elevation Myocardial Infarction
  • NSTEMI - Non-ST Segment Elevation MI
  • STEMI
  • NSTEMI
  • Acute Myocardial Infarction of Right Ventricle (Disorder)
  • Acute Myocardial Infarction of Left Ventricle
  • Acute Myocardial Infarction With ST Elevation

Sponsors & Collaborators

  • Abiomed Inc.

    collaborator INDUSTRY

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Mir B Basir, DO · Henry Ford Health

  • William W O'Neill, MD · Henry Ford Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-22
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800951 on ClinicalTrials.gov